Exploring Macrophage Contribution to Vascular Calcification in Atherosclerosis.

Area of Science:

• Cardiovascular Biology
• Immunology
• Pathology

Background:

• Vascular calcification (VC) is a critical factor in atherosclerosis, increasing cardiovascular morbidity and mortality.
• VC is particularly prevalent in patients with diabetes and chronic kidney disease (CKD).
• Macrophages are key cellular players in the development and progression of VC within atherosclerotic plaques.

Purpose of the Study:

• To review the pivotal role of macrophages in vascular calcification (VC).
• To explore the distinct functions of M1 and M2 macrophage phenotypes in modulating vascular smooth muscle cell (VSMC) behavior and calcification.
• To highlight microRNAs (miRNAs) as potential therapeutic targets for regulating macrophage activation in VC.

Main Methods:

• Literature review focusing on macrophage phenotypes (M1 and M2) and their functions in VC.
• Analysis of cellular and molecular mechanisms of macrophage-mediated calcification.
• Examination of the influence of macrophage balance on osteoclastic differentiation and calcified deposit resorption.

Main Results:

• M1 macrophages promote VSMC transdifferentiation and calcification via pro-inflammatory cytokines (e.g., OSM, BMP).
• M2 macrophages exhibit protective effects that may mitigate excessive vascular calcification.
• The balance of macrophage populations influences osteoclastic differentiation and the resorption of calcified deposits.

Conclusions:

• Macrophages have dual roles in atherosclerosis-related VC, acting as both promoters and potential mitigators.
• Understanding macrophage phenotypes and their regulation by miRNAs is crucial for developing novel therapeutic strategies.
• Targeting macrophage pathways could improve cardiovascular health outcomes, especially in high-risk populations like those with diabetes and CKD.